Funded Projects › HORIZON
GEMINI · Towards GEMINI: A Generation of Multi-scale Digital Twins of Ischaemic and Haemorrhagic Stroke Patients
GEMINI aims to deliver validated multi-organ and multi-scale computational models for treatment decision support and improved fundamental understanding of acute strokes, both ischaemic and haemorrhagic. We will demonstrate the added benefit of these computational models in personalised disease management. Specifically, GEMINI will deliver validated, integrated multi-scale, multi-organ Digital Twin in Healthcare (DTH) models for cerebral blood and cerebrospinal fluid flow, brain perfusion and metabolism, and blood flow and thrombosis along the heart-brain axis by integrating available and newly developed dynamic, interoperable, and modular computational models. Building on these models, GEMINI will deliver validated population-based DTHs of ischemic and haemorrhagic stroke aetiology and onset, treatment, and disease progression. Utilising these population-based DTHs, GEMINI will validate five personalised subject-specific DTHs, (1) stroke treatment, and (2) disease progression DTHs for acute ischaemic stroke and (3) aneurysm treatment, (4) subarachnoid haemorrhage progression, and (5) unruptured intracranial aneurysm risk assessment DTHs for haemorrhagic stroke to guide patient care and long-term management. We will bring proof of value of digital twins by the evaluation of the ischaemic stroke treatment selection DTH in a multi-centre clinical trial, in which treatment and patient outcomes are compared in situations with and without the availability of a DTH. GEMINI will implement a project-wide structured approach for data harmonisation, curation, model validation, verification, and model certification of the DTHs. Several outcomes of GEMINI have a high value for clinical practice, medical device industry, and in enhancing research in the fields of (bio)medical and computer sciences, warranting an extensive valorisation strategy with adequate IP protection and versatile exploitation actions to enhance a wide adaptation of the results of GEMINI.
Consortium · 22 organisations
STICHTING AMSTERDAM UMC
NL · €2,962,670
UNIVERSIDAD POMPEU FABRA
ES · €532,500
UNIVERSITY OF GALWAY
IE · €603,858
AKADEMIA GORNICZO-HUTNICZA IM. STANISLAWA STASZICA W KRAKOWIE
PL · €443,750
SIM&CURE
FR · €281,250
SANO CENTRUM ZINDYWIDUALIZOWANEJ MEDYCYNY OBLICZENIOWEJ MIEDZYNARODOWA FUNDACJA BADAWCZA
PL · €532,500
BUDAPESTI MUSZAKI ES GAZDASAGTUDOMANYI EGYETEM
HU · €537,250
UNIVERSITY OF CAPE TOWN
ZA
NATIONAL TAIWAN UNIVERSITY
TW
RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAT BONN
DE · €406,250
NEURAVI LIMITED
IE · €603,750
LES HOPITAUX UNIVERSITAIRES DE GENEVE
CH
POLITECNICO DI MILANO
IT · €587,500
INSTEPS BV
NL · €162,500
AMSTERDAM UMC RESEARCH BV
NL
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
NL · €553,885
CRANFIELD UNIVERSITY
UK
ZURCHER HOCHSCHULE FUR ANGEWANDTE WISSENSCHAFTEN
CH
ANSYS FRANCE SAS
FR · €299,000
NICO-LAB BV
NL · €280,610
TECHNISCHE UNIVERSITEIT DELFT
NL · €337,605
UNIVERSITEIT VAN AMSTERDAM
NL · €867,000
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.